Skip to main content
Access
Home Alt+0
Navigation Alt+1
Content Alt+2
Language
عربي
中文
English
Français
Русский
Español
Navigation
Home
Health topics
Data and statistics
Media centre
Publications
Countries
Programmes and projects
About
WHO
Search
Search the
WHO
.int site
Submit
Advanced search
Medicines
Subnavigation
Medicines
About us
News and events
Areas of work
Medicines publications
Medicines topics
Training resources
45th Expert Committee on Specifications for Pharmaceutical Preparations
Geneva, 18-22 October 2010
Draft agenda
pdf, 35kb
Draft timeframe for open and Expert Committee sessions
pdf, 22kb
For submissions of comments please use the following forms...
Example form
pdf, 48kb
Submission form
doc, 54kb
Working documents
Regulatory guidance:
Quality requirements for Artemisinin as a starting material in the production of Antimalarial active pharmaceutical Ingredients (APIs)
pdf, 229kb
Pharmaceutical development for multisource (generic) pharmaceutical products
pdf, 726kb
Guideline on submission of documentation for a multisource (generic) finished pharmaceutical product (FPP): quality part
pdf, 1.45Mb
Guideline on submission of documentation for a multisource (generic) finished pharmaceutical product (FPP): Preparation of product dossiers (PDS) in common technical document (CTD) format
pdf, 722kb
WHO guidelines for drafting a site master filê
pdf, 146kb
Development of paediatric medicines: points to consider in pharmaceutical development
pdf, 575kb
GMP:
Supplementary guidelines on Good Manufacturing Practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms
Proposal for revision
pdf, 1.41Mb
WHO Good Manufacturing Practices: water for pharmaceutical use
proposal for revision
pdf, 507kb
Proposed new sections for WHO Good Manufacturing Practices (GMP): Main principles for pharmaceutical products
pdf, 225kb
Distribution and related practices :
Joint FIP/WHO guidelines on good pharmacy practice: Standards for quality of pharmacy services
pdf, 476kb
Quality assurance guidance:
WHO guiding principles on transfer of technology
pdf, 523kb
WHO guideline on quality risk management
pdf, 536kb
Laboratory:
WHO good practices for pharmaceutical microbiological laboratories
pdf, 570kb
Who guidelines for preparing a laboratory information file
Proposal for revision
pdf, 213kb
Prequalification:
Prequalification of quality control laboratories. Procedure for assessing the acceptability, in principle, of quality control laboratories for use by United Nations agencies. Proposal for revision
pdf, 353kb
Guide on submission of documentation for prequalification of innovator FPPs
approved by SRAs
pdf, 114kb
Procedure for prequalification of pharmaceutical products. proposal for modification
pdf, 380kb
Legislation and nomenclature:
New definition for substandard medicines
pdf, 88kb
Preliminary Draft Survey on National Legislation on spurious/falsely-labelled/falsified/counterfeit medical products (WHO/ACM/1)
pdf, 596kb
Draft principles and elements for national legislation against spurious/falsely-labelled/falsified/counterfeit medical products (IMPACT)
pdf, 189kb
Report of the situation of counterfeit medicines based on data collection tool WHO Regions for Africa and Eastern Mediterranean
pdf, 1.06Mb
Specifications
Anti-infectives
Amoxicillin oral suspension
pdf, 184kb
Metronidazole oral suspension
pdf, 154kb
Levamisole tablets
pdf, 172kb
Sulfamethoxazole and trimethoprim tablets
pdf, 178kb
Antimalarials:
Artesunate powder for injection
pdf, 211kb
Mefloquine tablets
pdf, 259kb
Sulfadoxine and pyrimethamine tablets
pdf, 292kb
Anti-TB:
Capreomycin sulfate
pdf, 246kb
Capreomycin injection
pdf, 150kb
Ofloxacin
pdf, 269kb
Levofloxacin
pdf, 204kb
Ofloxacin-tabs
pdf, 195kb
Levofloxacin-tabs
pdf, 196kb
ARVs:
Emtricitabine + Tenofovir disoproxil fumarate tablets
pdf, 171kb
Emtricitabine + Tenofovir disoproxil fumarate + Efavirenz tablets
pdf, 187kb
Emtricitabine capsules
pdf, 170kb
Efavirenz tabs (QAS/10.355/Rev.1)
pdf, 172kb
Disanosine capsules (QAS/10.356/Rev.1)
pdf, 187kb
Other medicines:
Sodium bicarbonate intravenous infusion
pdf, 120kb
Retinol concentrate, oily form (API)
pdf, 267kb
Levonorgestrel tablets
pdf, 186kb
Oseltamivir caps (QAS/10.363/Rev.1)
pdf, 153kb
Paracetamol solution (QAS/10.385)
pdf, 147kb
Paracetamol suspension (QAS/10.386)
pdf, 126kb
Paediatric:
Paediatric Retinol capsules
pdf, 203kb
Paediatric Retinol oral solution
pdf, 204kb
Share
Email
Twitter
Facebook
Google
Delicious
LinkedIn
More...
Print
You are here:
Medicines
Services
Expert Committee on Specifications for Pharmaceutical Preparations